CD274 and neoplasm: Programmed death-1 (PD-1), are frequently exploited through overactivation by their specific ligands [e.g., programmed death ligand 1 (PD-L1)] that are expressed on cancer and immune cells, leading to peripheral T cell exhaustion, and thus allowing for tumor escape from immune surveillance (Fabris et al., 2019).